|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The effect of combination therapy with metformin and combined oral |
| contraceptives (COC) versus COC alone on insulin sensitivity, |
| hyperandrogenaemia, SHBG and lipids in PCOS patients. |
| Cibula D; Fanta M; Vrbikova J; Stanicka S; Dvorakova K |
| Human Reproduction. 2004;20(1):180-184. |
| Neither oral contraceptives (COC) nor metformin are an optimal modality for the long-term treatment of polycystic ovary |
| syndrome (PCOS). The aim of this study was to evaluate whether a combination of both is beneficial over COC |
| monotherapy. Altogether, 30 women were included in the study and 28 finished the protocol. The patients were |
| randomly assigned to two groups treated with either COC (COC group) or COC and metformin (1500 mg/day) (METOC |
| group) for 6 months. Anthropometric parameters, androgens, lipids, fasting insulin, glucose and sex hormone binding |
| globulin (SHBG) concentrations were measured before and at the end of the sixth cycle of treatment. The insulin |
| sensitivity index was evaluated using the euglycaemic clamp. There were no significant changes in anthropometric |
| parameters, fasting glucose or insulin sensitivity in either group. Total testosterone, free androgen index, |
| androstenedione and dehydroepiandrosterone decreased and SHBG increased significantly in both groups. When |
| comparing the effect of both treatments, only a more pronounced decrease in free androgen index was found in the |
| METOC group. Adding metformin slightly modified the treatment effect of COC, causing a more significant decrease |
| in the free androgen index but having no additional positive impact on lipids, insulin sensitivity, SHBG or |
| testosterone. The available data do not offer enough evidence to advocate the standard use of combined treatment in |
| PCOS. Whether the combination might be beneficial for specific subgroups of patients is of further interest. |
| (PubHealth.info Document ID: CONT1T 529-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The effect of combination therapy with metformin and |
| combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids |
| in PCOS patients.", is(are) Cibula D; Fanta M; Vrbikova J; Stanicka S; Dvorakova K. The source of this article is |
| "Human Reproduction. 2004;20(1):180-184.". This article was published in 2004 in English language(s). |
| (PubHealth.info® Document ID: CONT1T 529-06. All rights reserved with PubHealth.info) PIN: 529 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |